Ian Henderson

Ian is a chemist with more than 10 years of experience in various chemical and biotechnology fields. After obtaining a B.S. in biomedical engineering from Case Western Reserve University, he earned an M.S. and Ph.D. in polymer science and engineering from the University of Massachusetts, Amherst, investigating novel polymer synthetic routes as well as the chemistry and physics of polymer and small molecular coordination compounds. After matriculation, Ian worked as a postdoctoral researcher at Sandia National Laboratories in the areas of polymer self-assembly, organic synthesis, protein chemistry, and biochemistry. Ian is the founder and CEO of Omphalos Bioscience, LLC, a company developing a new class of antibiotics, and he also collaborates with the research arm of the Raymond G. Murphy VA Medical Center, investigating cellular signaling in the mammalian microbiome.